Find a Doctor

LM
Areas of Expertise

Laurent Machet

University Of Tours
Male

Bio

Laurent Machet is in Chambray-les-tours, France. They have been an author on 147 peer reviewed articles and participated in 5 clinical trials in the past 15 years.

Areas of Expertise

Contact

Chambray-les-tours, FR

Latest Research

Latest Advance
Study
  • Condition: Pemphigus Vulgaris
  • Journal: The British journal of dermatology
  • Treatment Used: Rituximab
  • Number of Patients: 38
  • Published —
The study researched the safety and effectiveness of Rituximab in patients with pemphigus vulgaris.
Latest Advance
Study
  • Condition: Melanoma
  • Journal: The Lancet. Oncology
  • Treatment Used: MAGE-A3 immunotherapeutic
  • Number of Patients: 3914
  • Published —
This study evaluated the efficacy of the MAGE-A3 immunotherapeutic as adjuvant therapy in patients with stage IIIB or IIIC melanoma.
Latest Advance
Study
  • Condition: KIT-Altered Melanoma
  • Journal: The Journal of investigative dermatology
  • Treatment Used: Nilotinib
  • Number of Patients: 25
  • Published —
This study evaluated the response rate at 6 months using mutated oncogenic KIT as a therapeutic target in melanoma.

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 42
  • Start Date: September 20, 2020
Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 130
  • Start Date: July 11, 2019
Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 60
  • Start Date: April 17, 2019
Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 270
  • Start Date: October 30, 2018
Combination of Targeted Therapy (Encorafenib and Binimetinib) Followed by Combination of Immunotherapy (Ipilimumab and Nivolumab) vs Immediate Combination of Immunotherapy in Patients With Unresectable or Metastatic Melanoma With BRAF V600 Mutation : an EORTC Randomized Phase II Study (EBIN)
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 70
  • Start Date: March 6, 2017
An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy on Chronic Pruritus in Adults With Plaque Psoriasis

All Publications
View All

Publication
Study
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Published —
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.
Publication
Study
  • Journal: Acta dermato-venereologica
  • Published —
Erosive Plaques with Excessive Granulation Tissue on the Scalp: A Quiz.

Contact

Chambray-les-tours, FR

Insurance

Contact them to find out if they accept your insurance plan.